Page last updated: 2024-10-21

2-aminoethoxydiphenyl borate and Parkinson Disease, Secondary

2-aminoethoxydiphenyl borate has been researched along with Parkinson Disease, Secondary in 1 studies

2-aminoethoxydiphenyl borate: is a novel membrane-penetrable modulator and transient receptor potential channel blocker; structure in first source; do not confuse with 2-APB cpd
2-aminoethoxydiphenylborane : An organoboron compound that is diphenylborane in which the borane hydrogen is replaced by a 2-aminoethoxy group.

Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
An, X1
Fu, Z1
Mai, C1
Wang, W1
Wei, L1
Li, D1
Li, C1
Jiang, LH1

Other Studies

1 other study available for 2-aminoethoxydiphenyl borate and Parkinson Disease, Secondary

ArticleYear
Increasing the TRPM2 Channel Expression in Human Neuroblastoma SH-SY5Y Cells Augments the Susceptibility to ROS-Induced Cell Death.
    Cells, 2019, 01-08, Volume: 8, Issue:1

    Topics: Alzheimer Disease; Boron Compounds; Cell Death; Cell Line, Tumor; Cell Survival; Humans; Hydrogen Pe

2019